ISSN: 2278-0238

薬学および生命科学における研究開発の国際ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Outline of Risks and Opportunities for Nepal's Pharmacy Data Systems

Haavid H

Healthcare professionals and patients can access current information on many aspects of drugs through the Drug Information Center (DIC) or Medicine Information Services. By fostering medication knowledge and supporting pharmaceutical services, medicine information services also help to reduce medication errors. This reflective commentary's main goals are to emphasize the current state of Nepal's medical information services, DIC problems,DIC strengthening strategies, and DIC prospects for the future. It is now simpler to evaluate the information in a nation like Nepal thanks to the availability of medicine information on multiple online drug information sites and programmers (apps). Before being shared, this information's veracity and dependability should be examined. By assisting doctors in using pharmaceuticals more safely and encouraging adverse drug reaction (ADR) reporting in Nepal, DIC plays a critical role in enhancing drug safety. There is not enough financial support in Nepal to run the DIC effectively, which causes operational issues. To guarantee the high quality of the service, the effectiveness of the nation's medical information services should be assessed on a regular basis. The government, private hospitals, and regulatory organizations should take action to maintain the current DIC and to build new DICs in the future to offer the community high-quality healthcare services.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。